Paracetamol use prior to and in early pregnancy: Prevalence and patterns among women with and without chronic medical diseases
British Journal of Clinical Pharmacology · 2023-08 · 89 (8) · 2582-2591
DOI: 10.1111/bcp.15732 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 18.04.2023. Verfasst von Mille Taagaard und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, The Juliane Marie Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Mental Disorders, Migraine Disorders. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Aims
Paracetamol is commonly consumed by pregnant women, even though recent data have questioned its safety. Having chronic medical diseases (CMDs) may influence the prevalence of use during pregnancy. We aimed to assess the prevalence and patterns of use 3 months prior to pregnancy and in the first trimester among women with and without CMDs and the potential influence of CMDs on frequent use in the first trimester.
Methods
We used patient‐reported data from the Copenhagen Pregnancy Cohort from 1 October 2013 to 23 May 2019 with information on CMDs and paracetamol use. Prevalence and patterns of use were assessed descriptively and by multivariable logistic regression models.
Results
We included 24 019 pregnancies. Use of paracetamol prior to and in early pregnancy was significantly higher among women with CMDs compared to women without (40.7% vs . 35.8% and 9.1% vs . 5.1%, respectively). Women with CMDs were 2.7 times more likely to have a frequent intake compared to women without [aOR 2.69 (95% CI 2.05–3.32)]. Migraine, rheumatoid arthritis and mental disease were associated with a higher use of paracetamol [aOR 4.39 (3.20–6.02), aOR 4.32 (2.41–7.72) and aOR 2.74 (1.67–4.49), respectively].
Conclusions
Women with CMDs had a higher paracetamol use before and during pregnancy than women without CMDs. Women with migraine, rheumatoid arthritis and mental disease showed the highest risk of frequent use. This study highlights the importance of discussing pain relief in pregnancy and evaluating the influence of maternal CMDs when assessing adverse effects of paracetamol use during pregnancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics, The Juliane Marie Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
- Department of Clinical Biochemistry, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
- Department of Obstetrics, Center for Fetal Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
- Department of Gynaecology and Obstetrics, Copenhagen University Hospital, Amager-Hvidovre, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- Department of Growth and Reproduction, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Mille Taagaard, Ane Lilleøre Rom
Zitieren
APA
Taagaard, M., Rode, L., de Wolff, M. G., Damm, P., Hagen, C. P., Fisher, M. B., Hegaard, H. K., & Rom, A. L. (2023). Paracetamol use prior to and in early pregnancy: Prevalence and patterns among women with and without chronic medical diseases. British Journal of Clinical Pharmacology, 89(8), 2582-2591. https://doi.org/10.1111/bcp.15732
Vancouver
Taagaard M, Rode L, de Wolff MG, Damm P, Hagen CP, Fisher MB, et al. Paracetamol use prior to and in early pregnancy: Prevalence and patterns among women with and without chronic medical diseases. British Journal of Clinical Pharmacology. 2023;89(8):2582-2591. doi:10.1111/bcp.15732
BibTeX
@article{Taagaard2023,
author = {Taagaard, Mille and Rode, Line and de Wolff, Mie Gaarskjaer and Damm, Peter and Hagen, Casper P and Fisher, Margit Bistrup and Hegaard, Hanne Kristine and Rom, Ane Lilleøre},
title = {Paracetamol use prior to and in early pregnancy: Prevalence and patterns among women with and without chronic medical diseases},
journal = {British Journal of Clinical Pharmacology},
year = {2023},
volume = {89},
number = {8},
pages = {2582--2591},
doi = {10.1111/bcp.15732}
}
EUVIMED